GC
AMRX icon

Globeflex Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Globeflex Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Buy
146,508
+205
+0.1% +$2.81K 0.32% 92
2026
Q1 		$1.82M Buy
146,303
+9,798
+7% +$132K 0.28% 102
2025
Q4 		$1.72M Buy
136,505
+104,321
+324% +$1.19M 0.26% 99
2025
Q3 		$322K Sell
32,184
-124,355
-79% -$1.12M 0.05% 273
2025
Q2 		$1.27M Hold
156,539
– – 0.1% 161
2025
Q1 		$1.31M Buy
156,539
+12,100
+8% +$101K 0.12% 145
2024
Q4 		$1.14M Buy
144,439
+5,245
+4% +$44K 0.1% 171
2024
Q3 		$1.16M Sell
139,194
-9,841
-7% -$77K 0.11% 164
2024
Q2 		$946K Buy
149,035
+14,666
+11% +$93.1K 0.1% 181
2024
Q1 		$812K Hold
134,369
– – 0.08% 210
2023
Q4 		$817K Hold
134,369
– – 0.08% 214
2023
Q3 		$567K Sell
134,369
-5,834
-4% -$21.8K 0.07% 240
2023
Q2 		$435K Sell
140,203
-8,504
-6% -$18.1K 0.05% 265
2023
Q1 		$207K Hold
148,707
– – 0.03% 338
2022
Q4 		$296K Hold
148,707
– – 0.04% 314
2022
Q3 		$300K Hold
148,707
– – 0.05% 315
2022
Q2 		$473K Hold
148,707
– – 0.12% 220
2022
Q1 		$620K Hold
148,707
– – 0.13% 204
2021
Q4 		$712K Hold
148,707
– – 0.15% 204
2021
Q3 		$794K Sell
148,707
-326,045
-69% -$1.64M 0.17% 188
2021
Q2 		$2.43M Buy
474,752
+450,400
+1,850% +$2.56M 0.44% 61
2021
Q1 		$164K Sell
24,352
-141,246
-85% -$783K 0.03% 386
2020
Q4 		$757K Sell
165,598
-86,098
-34% -$382K 0.16% 214
2020
Q3 		$977K Buy
251,696
+11,016
+5% +$47.1K 0.26% 132
2020
Q2 		$1.15M Buy
240,680
+50,496
+27% +$208K 0.29% 106
2020
Q1 		$662K Buy
+190,184
New +$805K 0.2% 171

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Globeflex Capital's AMRX Position: Q2 2026 in Review

Globeflex Capital increased its Amneal Pharmaceuticals (AMRX) stake by 0.14% in Q2 2026, buying an estimated $2.81K and bringing the position to 146,508 shares worth $2.54M. The position accounts for 0.32% of the portfolio, ranked #92.

Globeflex Capital first reported a position in AMRX in Q1 2020 and has held it in 26 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Globeflex Capital held 146,508 shares of Amneal Pharmaceuticals worth $2.54M as of Q2 2026.
  • Globeflex Capital bought 205 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.81K.
  • Amneal Pharmaceuticals made up 0.32% of Globeflex Capital's portfolio in Q2 2026, its #92 holding.
  • Globeflex Capital first reported a position in Amneal Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.